Clinical Trial

Pharmacokinetics of Oxytocin at Cesarean Delivery

Study Description

Pharmacokinetics of Oxytocin at Cesarean Delivery

The primary objective is to obtain data to inform the design of a population pharmacokinetic study of oxytocin after administration at CD as per standard institutional practice.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - oxytocin

PK measurements of oxytocin

Device - Shore durometer

The investigators will take serial readings from a digital durometer at the uterine fundus at 3, 6, 9 and 12 minutes following OXT administration to provide data that will inform an estimate of the timing of peak effect. Shore durometers measure the hardness of materials on a scale of 0-100 Shore Units (SU). Preliminary (unpublished) data provided a range of 10-56 SU after oxytocin administration at cesarean delivery. Durometer readings were also shown to correlate positively with the obstetrici ...read more on ClinicalTrials.org

Additional Information

Official Study Title

The Pharmacokinetics of Oxytocin in Pregnant Women Undergoing Cesarean Delivery - a Feasibility Pilot Study

Clinical Trial ID

NCT03898882

ParticipAid ID

bkRVKa